| Tristan A Clements, DPT | |
|
131 N Oak St, Blackfoot, ID 83221-1757 | |
| (208) 684-2444 | |
| Not Available |
| Full Name | Tristan A Clements |
|---|---|
| Gender | Male |
| Speciality | Physical Therapist |
| Location | 131 N Oak St, Blackfoot, Idaho |
| Accepts Medicare Assignments | Medicare enrolled and may accept medicare through third-party reassignment. May prescribe medicare part D drugs. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1467138636 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 225100000X | Physical Therapist | PT8566 (Idaho) | Primary |
| Provider Name | Wright Physical Therapy Limited Partnership |
|---|---|
| Provider Type | Part B Supplier - Physical/occupational Therapy Group In Private Practice |
| Provider Identifiers | NPI Number: 1730732025 PECOS PAC ID: 1759612641 Enrollment ID: O20191007003583 |
News Archive
Percutanous angioplasty involves insertion of a stent into a blocked or narrowed coronary artery that eases the blood flow and relieves the pain of severe angina or a heart attack. It is being routinely practiced worldwide. A new study called ORBITA, has revealed that not all patients who undergo this procedure benefit from it.
Medicity—the leading provider of health information exchange (HIE) solutions that empower physicians, hospitals and communities to improve care coordination, collaboration and achieve meaningful use of health information technology—today announced the U.S. Patent and Trademark Office has awarded the company Patent No. 7,653,634 for its agent-grid technology for health information exchange. This patented technology, which is at the core of Medicity's Novo Grid, has become the industry standard for seamless electronic health record (EHR) integration and community-wide health information exchange.
The U.S. Supreme Court on Wednesday ruled 6-3 that consumers harmed by an FDA-approved pharmaceutical product can sue the drugmaker for liability in state courts, the San Francisco Chronicle reports (Egelko, San Francisco Chronicle, 3/5).
The U.S. Food and Drug Administration today approved Imfinzi (durvalumab) for the treatment of patients with stage III non-small cell lung cancer (NSCLC) whose tumors are not able to be surgically removed (unresectable) and whose cancer has not progressed after treatment with chemotherapy and radiation (chemoradiation).
A first-of-its kind study using robotic technology to remotely control coronary guidewires and stents reported on the feasibility of performing percutaneous coronary intervention (PCI) on patients with complex coronary lesions. Similar clinical outcomes compared to the PCI procedure performed manually were reported.
› Verified 9 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Tristan A Clements, DPT 1411 Falls Ave E, Twin Falls, ID 83301-3455 Ph: () - | Tristan A Clements, DPT 131 N Oak St, Blackfoot, ID 83221-1757 Ph: (208) 684-2444 |
News Archive
Percutanous angioplasty involves insertion of a stent into a blocked or narrowed coronary artery that eases the blood flow and relieves the pain of severe angina or a heart attack. It is being routinely practiced worldwide. A new study called ORBITA, has revealed that not all patients who undergo this procedure benefit from it.
Medicity—the leading provider of health information exchange (HIE) solutions that empower physicians, hospitals and communities to improve care coordination, collaboration and achieve meaningful use of health information technology—today announced the U.S. Patent and Trademark Office has awarded the company Patent No. 7,653,634 for its agent-grid technology for health information exchange. This patented technology, which is at the core of Medicity's Novo Grid, has become the industry standard for seamless electronic health record (EHR) integration and community-wide health information exchange.
The U.S. Supreme Court on Wednesday ruled 6-3 that consumers harmed by an FDA-approved pharmaceutical product can sue the drugmaker for liability in state courts, the San Francisco Chronicle reports (Egelko, San Francisco Chronicle, 3/5).
The U.S. Food and Drug Administration today approved Imfinzi (durvalumab) for the treatment of patients with stage III non-small cell lung cancer (NSCLC) whose tumors are not able to be surgically removed (unresectable) and whose cancer has not progressed after treatment with chemotherapy and radiation (chemoradiation).
A first-of-its kind study using robotic technology to remotely control coronary guidewires and stents reported on the feasibility of performing percutaneous coronary intervention (PCI) on patients with complex coronary lesions. Similar clinical outcomes compared to the PCI procedure performed manually were reported.
› Verified 9 days ago
Tyce Alden Stewart, DPT Physical Therapist Medicare: Accepting Medicare Assignments Practice Location: 285 W Francis St, Blackfoot, ID 83221 Phone: 208-785-0123 Fax: 208-782-1885 | |
Bryan J. Gibby, MSPT, CWS Physical Therapist Medicare: Not Enrolled in Medicare Practice Location: 1492 Christensen Dr, Blackfoot, ID 83221 Phone: 208-240-7221 | |
Jessica Annelaine Vandyke, DPT Physical Therapist Medicare: Medicare Enrolled Practice Location: 282 W Bridge St, Blackfoot, ID 83221 Phone: 208-684-0021 | |
Brian Don Boehme, Physical Therapist Medicare: Not Enrolled in Medicare Practice Location: 1441 Parkway Dr, Blackfoot, ID 83221 Phone: 208-785-2600 | |
Pete Richar Johnson, Physical Therapist Medicare: Medicare Enrolled Practice Location: 131 N Oak St, Blackfoot, ID 83221 Phone: 208-684-2444 | |
Mr. Dustin Cade Schmitt, MPT, CSCS Physical Therapist Medicare: Not Enrolled in Medicare Practice Location: 285 W Francis St, Blackfoot, ID 83221 Phone: 208-785-0123 | |
Jonathan Dac-moang Liem, DPT Physical Therapist Medicare: Medicare Enrolled Practice Location: 1441 Parkway Dr Ste 1, Blackfoot, ID 83221 Phone: 208-785-3446 Fax: 208-980-7241 |